Literature DB >> 24623006

Reply.

O Sabri1.   

Abstract

Year:  2001        PMID： 24623006     DOI： 10.1007/s002590000467

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  8 in total

1.  Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma.

Authors:  F A Leger; M Izembart; F Dagousset; L Barritault; G Baillet; A Chevalier; J Clerc
Journal:  Eur J Nucl Med       Date:  1998-03

2.  Does thyroid stunning exist? A model with benign thyroid disease.

Authors:  O Sabri; M Zimny; M Schreckenberger; A Meyer-Oelmann; P Reinartz; U Buell
Journal:  Eur J Nucl Med       Date:  2000-11

3.  Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients.

Authors:  R K Jeevanram; D H Shah; S M Sharma; R D Ganatra
Journal:  Int J Rad Appl Instrum B       Date:  1986

4.  Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.

Authors:  O Sabri; M Zimny; G Schulz; M Schreckenberger; P Reinartz; K Willmes; U Buell
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

5.  Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma.

Authors:  M A Flower; T Schlesinger; P J Hinton; I Adam; A M Masoomi; M A Elbelli; R J Ott; V R McCready; C L Harmer
Journal:  Radiother Oncol       Date:  1989-08       Impact factor: 6.280

6.  Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.

Authors:  H M Park; O W Perkins; J W Edmondson; R B Schnute; A Manatunga
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

7.  Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers.

Authors:  J Nĕmec; S Röhling; V Zamrazil; D Pohunková
Journal:  J Nucl Med       Date:  1979-02       Impact factor: 10.057

8.  Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.

Authors:  J P Muratet; A Daver; J F Minier; F Larra
Journal:  J Nucl Med       Date:  1998-09       Impact factor: 10.057
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.